Mahinay, Ricardo B.
HRN: 05-92-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/07/2023
02/13/2023
IV
1.5g
Q6
Diabetic Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes